{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:50:44Z","timestamp":1794585044715,"version":"4.9.1"},"reference-count":211,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007725","name":"Astrobiology Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.chest.2018.03.056","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T11:41:57Z","timestamp":1524570117000},"page":"664-677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":195,"title":["Drug-Induced Sarcoidosis-Like Reactions"],"prefix":"10.1016","volume":"154","author":[{"given":"Amit","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Nautiyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kalkanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2018.03.056_bib1","first-page":"2016","article-title":"Systemic sarcoidosis first manifesting in a tattoo in the setting of immune checkpoint inhibition","author":"Kim","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/RLU.0000000000000582","article-title":"Etanercept-induced sarcoidosis in rheumatoid arthritis: FDG PET findings","volume":"40","author":"Nakajima","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.chest.2018.03.056_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1471-2377-13-212","article-title":"Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis","volume":"13","author":"Durel","year":"2013","journal-title":"BMC Neurol"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(19870301)59:5<896::AID-CNCR2820590507>3.0.CO;2-4","article-title":"Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma","volume":"59","author":"Abdi","year":"1987","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib5","first-page":"249","article-title":"Adalimumab induced subcutaneous nodular sarcoidosis; a rare side effect of tumor necrosis factor-alpha inhibitor","volume":"31","author":"Au","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.chest.2018.03.056_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1529-8019.2009.01263.x","article-title":"Cutaneous lesions as initial signs of interferon alpha-induced sarcoidosis: report of three new cases and review of the literature","volume":"22 suppl 1","author":"Fantini","year":"2009","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib7","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","article-title":"Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma","volume":"149","author":"Danlos","year":"2016","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00417-008-1002-5","article-title":"Interferon-alpha-associated presumed ocular sarcoidosis","volume":"247","author":"Doycheva","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00000441-200409000-00008","article-title":"Interferon-alpha-associated sarcoidosis responsive to infliximab therapy","volume":"328","author":"Menon","year":"2004","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00042737-200208000-00013","article-title":"Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases","volume":"14","author":"Gitlin","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.chest.2018.03.056_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40425-016-0199-9","article-title":"Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature","volume":"4","author":"Reuss","year":"2016","journal-title":"J\u00a0Immunother Cancer"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/1078155216667635","article-title":"Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors","volume":"23","author":"Firwana","year":"2017","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"9","key":"10.1016\/j.chest.2018.03.056_bib13","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/1756-185X.13076","article-title":"Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: case series and immunophenotypic analysis","volume":"20","author":"Lomax","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Daien","year":"2009","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib16","first-page":"1355","article-title":"Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor","volume":"32","author":"Wilgenhof","year":"2012","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000161122","article-title":"Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient","volume":"218","author":"Eckert","year":"2009","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib18","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/j.jaad.2013.07.028","article-title":"Cutaneous and pulmonary sarcoidosis-like reaction associated with ipilimumab","volume":"69","author":"Reule","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1183\/09031936.00107912","article-title":"Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy","volume":"41","author":"Tissot","year":"2013","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10637-014-0092-7","article-title":"Kidney injuries related to ipilimumab","volume":"32","author":"Izzedine","year":"2014","journal-title":"Invest New Drugs"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000362614","article-title":"New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment","volume":"37","author":"Murphy","year":"2014","journal-title":"Oncol Res Treat"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib22","first-page":"1060","article-title":"Pulmonary sarcoid-like granulomatosis induced by nivolumab","volume":"176","author":"Montaudie","year":"2017","journal-title":"Br\u00a0J\u00a0Dermatol"},{"issue":"9","key":"10.1016\/j.chest.2018.03.056_bib23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/RLU.0000000000001758","article-title":"Nivolumab-induced development of pulmonary sarcoidosis in renal cell carcinoma","volume":"42","author":"Zhang","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdcr.2017.02.015","article-title":"Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma","volume":"3","author":"Birnbaum","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib25","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/annonc\/mdw193","article-title":"Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?","volume":"27","author":"Paydas","year":"2016","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib26","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/annonc\/mdw125","article-title":"Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab","volume":"27","author":"Cousin","year":"2016","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jdcr.2016.06.004","article-title":"Pembrolizumab-associated sarcoidosis","volume":"2","author":"Cotliar","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0033-2016","article-title":"Paradoxical reactions and the immune reconstitution inflammatory syndrome","volume":"5","author":"Church","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/381094","article-title":"Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"38","author":"Foulon","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib30","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1086\/317422","article-title":"Sarcoidosis after antiretroviral therapy in a patient with acquired immunodeficiency syndrome","volume":"31","author":"Gomez","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2230.2010.03929.x","article-title":"Cutaneous and pulmonary sarcoidosis in a patient with human immunodeficiency virus: a late feature of immune restoration syndrome","volume":"36","author":"Marti","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1590\/S1413-86702011000600018","article-title":"Immune reconstitution inflammatory syndrome associated with pulmonary sarcoidosis in an HIV-infected patient: an immunohistochemical study","volume":"15","author":"Miranda","year":"2011","journal-title":"Braz J Infect Dis"},{"issue":"2\u00a0pt\u00a02","key":"10.1016\/j.chest.2018.03.056_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0190-9622(99)70364-6","article-title":"Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome","volume":"41","author":"Mirmirani","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib34","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1164\/ajrccm.159.6.9807152","article-title":"Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy","volume":"159","author":"Naccache","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"935","key":"10.1016\/j.chest.2018.03.056_bib35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/pmj.79.935.535","article-title":"Sarcoidosis and HIV infection: a case report and a review of the literature","volume":"79","author":"Trevenzoli","year":"2003","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib36","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2214\/ajr.177.6.1771427","article-title":"Immune restoration syndrome manifested by pulmonary sarcoidosis","volume":"177","author":"Wittram","year":"2001","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.chest.2018.03.056_bib37","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1007\/s10620-008-0209-y","article-title":"Hepatic sarcoidosis associated with pegylated interferon alfa therapy for chronic hepatitis C: case report and review of literature","volume":"53","author":"Adla","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1742-1241.2005.00651.x","article-title":"Interferon-induced sarcoidosis","volume":"60","author":"Alazemi","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib39","first-page":"141","article-title":"Hyercalcemia induced by interferon therapy in chronic hepatitis C","volume":"19","author":"Albaker","year":"2012","journal-title":"J\u00a0Fam Community Med"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1478-3231.2009.02173.x","article-title":"A\u00a0levitating tattoo in a hepatitis C patient on treatment","volume":"30","author":"Atluri","year":"2010","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib41","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1478-3231.2010.02225.x","article-title":"Sarcoidosis or foreign-body granulomatous reaction during interferon treatment?","volume":"30","author":"Bitetto","year":"2010","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000346244","article-title":"Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis","volume":"226","author":"Buss","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.chest.2018.03.056_bib43","first-page":"2011","article-title":"Interferon-induced sarcoidosis","author":"Cardoso","year":"2011","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib44","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.0007-0963.2001.04570.x","article-title":"Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases","volume":"146","author":"Cogrel","year":"2002","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000128281","article-title":"Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases","volume":"217","author":"Descamps","year":"2008","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2133.1999.02687.x","article-title":"Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon-alpha treatment for chronic hepatitis C","volume":"140","author":"Eberlein-Konig","year":"1999","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib47","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/MEG.0b013e32833834bc","article-title":"Sarcoidosis and hepatitis C: clinical description of 11 cases","volume":"22","author":"Faurie","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3-4","key":"10.1016\/j.chest.2018.03.056_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3121\/cmr.2010.886","article-title":"Development of sarcoidosis following completion of treatment for hepatitis C with pegylated interferon-{alpha}2a and ribavirin: a case report and literature review","volume":"8","author":"Gayet","year":"2010","journal-title":"Clin Med Res"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib49","first-page":"834","article-title":"Sarcoidosis induced by interferon-alpha in melanoma patients: incidence, clinical manifestations, and management strategies","volume":"33","author":"Heinzerling","year":"2010","journal-title":"J\u00a0Immunother"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib50","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0168-8278(98)80357-7","article-title":"Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C","volume":"28","author":"Hoffmann","year":"1998","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archderm.141.7.865","article-title":"Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature","volume":"141","author":"Hurst","year":"2005","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib52","first-page":"1319","article-title":"A\u00a0case of cardiac sarcoidosis occurring during combination therapy by IFN alpha and ribavirin for chronic hepatitis C [in Japanese]","volume":"107","author":"Iwashita","year":"2010","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5021\/ad.2011.23.2.239","article-title":"Interferon-alpha induced sarcoidosis with cutaneous involvement along the lines of venous drainage","volume":"23","author":"Lee","year":"2011","journal-title":"Ann Dermatol"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-4632.2010.04728.x","article-title":"Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature","volume":"50","author":"Lopez","year":"2011","journal-title":"Int J Dermatol"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib55","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1023\/A:1015843908536","article-title":"Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature","volume":"47","author":"Nawras","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/120347540100500507","article-title":"Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b","volume":"5","author":"Neglia","year":"2001","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib57","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1600-0560.2011.01702.x","article-title":"Alpha-interferon induced sarcoidosis mimicking metastatic melanoma","volume":"38","author":"North","year":"2011","journal-title":"J\u00a0Cutan Pathol"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib58","first-page":"441","article-title":"Pulmonary and cutaneous sarcoidosis associated with interferon therapy for melanoma","volume":"80","author":"Pelletier","year":"2007","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib59","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2230.2006.02099.x","article-title":"Systemic sarcoidosis presenting in a tattooed man undergoing treatment for hepatitis C","volume":"31","author":"Perera","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2893.2002.00105.x","article-title":"Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine","volume":"9","author":"Perez-Alvarez","year":"2002","journal-title":"J\u00a0Viral Hepat"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1468-3083.2006.01867.x","article-title":"Cutaneous sarcoidosis limited to scars following pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C","volume":"21","author":"Perez-Gala","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.md.0000157577.69729.e6","article-title":"Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.chest.2018.03.056_bib63","doi-asserted-by":"crossref","first-page":"230417","DOI":"10.1155\/2010\/230417","article-title":"Subcutaneous sarcoidosis during pegylated interferon alfa and ribavirin treatment for chronic hepatitis C","volume":"2010","author":"Rodriguez-Lojo","year":"2010","journal-title":"Dermatol Res Pract"},{"issue":"12","key":"10.1016\/j.chest.2018.03.056_bib64","first-page":"4","article-title":"Interferon induced sarcoidosis with cutaneous involvement along lines of venous drainage in a former intravenous drug user","volume":"15","author":"Shuja","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.chest.2018.03.056_bib65","first-page":"2011","article-title":"Interferon alpha-induced sarcoidosis to a patient with polycythemia vera","author":"Sionidou","year":"2011","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib66","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archderm.138.4.546","article-title":"Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C","volume":"138","author":"Wendling","year":"2002","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1445-5994.2007.01625.x","article-title":"Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for hepatitis C","volume":"38","author":"Yan","year":"2008","journal-title":"Int Med J"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib68","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2340\/00015555-0724","article-title":"HLA typing in an IFN-alpha-induced scar sarcoidosis: possible pathogenetic and clinical implications","volume":"89","author":"Zampino","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib69","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1111\/ajco.12204","article-title":"First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma","volume":"12","author":"Jeon","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib70","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/hepr.12021","article-title":"Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy","volume":"43","author":"Joshita","year":"2013","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5152\/tjg.2016.0433","article-title":"Sudden-onset sarcoidosis with severe dyspnea developing during pegylated interferon and ribavirin combination therapy for chronic hepatitis C","volume":"28","author":"Kim","year":"2017","journal-title":"Turk J Gastroenterol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib72","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0953-6205(03)00078-5","article-title":"Sarcoidosis and interferon therapy: report of five cases and review of the literature","volume":"14","author":"Leclerc","year":"2003","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1016\/j.chest.2018.03.056_bib73","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1346-8138.12581","article-title":"Development of sarcoidosis during beta-interferon therapy for melanoma","volume":"41","author":"Shiki","year":"2014","journal-title":"J\u00a0Dermatol"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib74","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1111\/ijd.12676","article-title":"Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: case report","volume":"54","author":"Viana de Andrade","year":"2015","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib75","first-page":"29","article-title":"Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy","volume":"77","author":"Carbonelli","year":"2012","journal-title":"Monaldi Arch Chest Dis"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.semarthrit.2012.03.008","article-title":"Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review","volume":"42","author":"Chakravarty","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.chest.2018.03.056_bib77","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/1752-1947-6-344","article-title":"Interferon-beta-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report","volume":"6","author":"Petousi","year":"2012","journal-title":"J\u00a0Med Case Rep"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib78","first-page":"140","article-title":"Sarcoidosis following beta-interferon therapy for multiple myeloma","volume":"12","author":"Bobbio-Pallavicini","year":"1995","journal-title":"Sarcoidosis"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib79","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000275676","article-title":"Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases","volume":"220","author":"Dhaille","year":"2010","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib80","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.semarthrit.2008.11.003","article-title":"Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new \u201cclass effect\u201d paradoxical phenomenon. Two case reports and literature review","volume":"39","author":"Massara","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib81","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1053\/j.gastro.2014.12.040","article-title":"New-onset paresthesias in inflammatory bowel disease","volume":"148","author":"Simonetto","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib82","first-page":"471","article-title":"Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases","volume":"26","author":"Toussirot","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.chest.2018.03.056_bib83","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3899\/jrheum.090307","article-title":"Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge","volume":"36","author":"van der Stoep","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib84","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/1756-185X.12078","article-title":"Granulomatous disease in a child treated with etanercept","volume":"16","author":"Alhajri","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib85","first-page":"99","article-title":"Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab","volume":"25","author":"Almodovar","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib86","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2006.01949.x","article-title":"Granulomatous tattoo reaction in a patient treated with etanercept","volume":"21","author":"Bachmeyer","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib87","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0560.2011.01795.x","article-title":"Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab","volume":"39","author":"Burns","year":"2012","journal-title":"J\u00a0Cutan Pathol"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib88","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.amjoto.2012.12.016","article-title":"Sarcoidosis-like granulomatosis of the hypopharynx as a complication of anti-TNF therapy","volume":"34","author":"Christoforidou","year":"2013","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10067-010-1577-1","article-title":"Tumor necrosis factor-alpha (TNF-alpha)-blockade-induced hepatic sarcoidosis in psoriatic arthritis (PsA): case report and review of the literature","volume":"30","author":"Cuchacovich","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.chest.2018.03.056_bib90","first-page":"2013","article-title":"Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab","author":"Dragnev","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib91","first-page":"349","article-title":"Granulomatous hepatitis associated with etanercept therapy","volume":"35","author":"Farah","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.chest.2018.03.056_bib92","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1592\/phco.27.10.1446","article-title":"Pulmonary sarcoidosis associated with etanercept therapy","volume":"27","author":"Farah","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib93","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.crohns.2012.01.008","article-title":"Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab","volume":"6","author":"Fok","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib94","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/09273948.2011.623212","article-title":"Sarcoid intermediate uveitis following etanercept treatment: a case report and review of the literature","volume":"20","author":"Fonollosa","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib95","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.22238","article-title":"Development of sarcoidosis during etanercept therapy","volume":"55","author":"Gonzalez-Lopez","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib96","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10067-011-1704-7","article-title":"Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?","volume":"30","author":"Haroon","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib97","first-page":"645","article-title":"Sarcoid-related uveitis occurring during etanercept therapy","volume":"21","author":"Hashkes","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib98","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/art.11154","article-title":"Pulmonary rheumatoid nodules in an etanercept-treated patient","volume":"48","author":"Hubscher","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.chest.2018.03.056_bib99","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2169\/internalmedicine.47.0602","article-title":"Development of sarcoidosis during etanercept therapy","volume":"47","author":"Ishiguro","year":"2008","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10067-010-1603-3","article-title":"Sarcoid-like granulomatosis in patients treated with anti-TNFalpha factors. A case report and review of the literature","volume":"30","author":"Kanellopoulou","year":"2011","journal-title":"Clin Rheumat"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib101","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.rmr.2010.08.018","article-title":"Pulmonary sarcoidosis developing during treatment with etanercept [in French]","volume":"28","author":"Kerjouan","year":"2011","journal-title":"Rev Mal Respir"},{"issue":"11","key":"10.1016\/j.chest.2018.03.056_bib102","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1016\/j.crohns.2013.06.002","article-title":"Sarcoidosis during therapy with adalimumab in a Crohn's disease patient: a paradoxical effect","volume":"7","author":"Kotze","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib103","first-page":"648","article-title":"Sarcoid-like granulomatous disease following etanercept treatment for RA","volume":"34","author":"Kudrin","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib104","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/j.1440-0960.2011.00863.x","article-title":"Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists","volume":"53","author":"Lamrock","year":"2012","journal-title":"Aust J Dermatol"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib105","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2007.078840","article-title":"Relapse of sarcoidosis upon treatment with etanercept","volume":"67","author":"Louie","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib106","first-page":"651","article-title":"Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitors","volume":"260","author":"Mao-Draayer","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib107","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1111\/j.1440-0960.2010.00660.x","article-title":"Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis","volume":"52","author":"Marcella","year":"2011","journal-title":"Aust J Dermatol"},{"issue":"9","key":"10.1016\/j.chest.2018.03.056_bib108","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.crohns.2014.02.006","article-title":"Sarcoidosis complicating treatment with adalimumab for Crohn's disease","volume":"8","author":"McDonnell","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib109","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/1756-185X.12178","article-title":"Development of pulmonary and cardiac sarcoidosis during etanercept therapy","volume":"17","author":"Miyagi","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"10.1016\/j.chest.2018.03.056_bib110","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3899\/jrheum.080383","article-title":"Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis","volume":"35","author":"Ognenovski","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib111","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.22351","article-title":"Pulmonary sarcoidosis developing during infliximab therapy","volume":"55","author":"O'Shea","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib112","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib113","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.21336","article-title":"Granulomatous lung disease occurring during etanercept treatment","volume":"53","author":"Phillips","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib114","first-page":"648","article-title":"The development of sarcoidosis on antitumour necrosis factor therapy: a paradox","volume":"163","author":"Pink","year":"2010","journal-title":"Br\u00a0J\u00a0Dermatol"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib115","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/rheumatology\/ker166","article-title":"Acute sarcoidosis as parotid fever in rheumatoid arthritis under anti-tumor necrosis factor-alpha therapy","volume":"50","author":"Salvatierra","year":"2011","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.chest.2018.03.056_bib116","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-4632.2009.04080.x","article-title":"Facial granulomatous nodules during etanercept treatment for psoriasis","volume":"48","author":"Samimi","year":"2009","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib117","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.lpm.2014.06.028","article-title":"Sarcoidosis after adalimumab treatment in inflammatory rheumatic diseases: a report of two cases and literature review [in French]","volume":"44","author":"Scailteux","year":"2015","journal-title":"Presse Med"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib118","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00296-009-1349-x","article-title":"Development of sarcoidosis following etanercept treatment: a report of three cases","volume":"32","author":"Skoie","year":"2012","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib119","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10384-009-0691-6","article-title":"Uveitis associated with sarcoidosis exacerbated by etanercept therapy","volume":"53","author":"Suzuki","year":"2009","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3899\/jrheum.090647","article-title":"Abrupt development of sarcoidosis with a prodromal increase in plasma osteopontin in a patient with rheumatoid arthritis during treatment with etanercept","volume":"37","author":"Takatori","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib121","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1445-5994.2011.02612.x","article-title":"New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication","volume":"42","author":"Tong","year":"2012","journal-title":"Intern Med J"},{"issue":"11","key":"10.1016\/j.chest.2018.03.056_bib122","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3899\/jrheum.090030","article-title":"Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series","volume":"36","author":"Toussirot","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"6 suppl 1","key":"10.1016\/j.chest.2018.03.056_bib123","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/abd1806-4841.20132588","article-title":"Systemic sarcoidosis induced by etanercept: first Brazilian case report","volume":"88","author":"Unterstell","year":"2013","journal-title":"An Bras Dermat"},{"issue":"11","key":"10.1016\/j.chest.2018.03.056_bib124","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s10067-007-0594-1","article-title":"Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients","volume":"26","author":"Verschueren","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jbspin.2012.05.001","article-title":"Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy","volume":"80","author":"Vigne","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.rmr.2013.04.029","article-title":"[Severe hypercalcemia revealing sarcoidosis precipitated by etanercept]","volume":"31","author":"Watrin","year":"2014","journal-title":"Rev Mal Respir"},{"issue":"9","key":"10.1016\/j.chest.2018.03.056_bib127","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2169\/internalmedicine.54.4188","article-title":"Acute kidney injury due to renal sarcoidosis during etanercept therapy: a case report and literature review","volume":"54","author":"Akiyama","year":"2015","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib128","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1346-8138.12372","article-title":"Etanercept-induced sarcoidosis presented with scrotal lesion: a rare manifestation in genital area","volume":"41","author":"Chaowattanapanit","year":"2014","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.chest.2018.03.056_bib129","first-page":"53","article-title":"Adalimumab induced pulmonary sarcoid reaction","volume":"10","author":"Bhargava","year":"2013","journal-title":"Respir Med Case Rep"},{"issue":"10","key":"10.1016\/j.chest.2018.03.056_bib130","doi-asserted-by":"crossref","first-page":"e6156","DOI":"10.1097\/MD.0000000000006156","article-title":"Sarcoidosis associated with infliximab therapy in ulcerative colitis: a case report","volume":"96","author":"Gilca","year":"2017","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib131","doi-asserted-by":"crossref","first-page":"e000239","DOI":"10.1136\/rmdopen-2015-000239","article-title":"Paradoxical reactions under TNF-alpha blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview","volume":"2","author":"Toussirot","year":"2016","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib132","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/RHU.0b013e3181efa190","article-title":"Tumor necrosis factor-alpha antagonist-induced sarcoidosis","volume":"16","author":"Clementine","year":"2010","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib133","first-page":"1222","article-title":"Cutaneous granulomas during infliximab therapy for spondyloarthropathy","volume":"35","author":"Dubosc","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib134","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.arbres.2010.05.011","article-title":"Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review","volume":"47","author":"Gifre","year":"2011","journal-title":"Arch Bronconeumol"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib135","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jbspin.2009.02.003","article-title":"Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient","volume":"76","author":"Josse","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib136","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.revmed.2011.03.336","article-title":"Pulmonary and renal involvement in a TNFalpha antagonist drug-induced sarcoidosis [in French]","volume":"33","author":"Olivier","year":"2012","journal-title":"Rev Med Interne"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib137","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1346-8138.2010.00861.x","article-title":"Sarcoidosis during infliximab therapy for Crohn's disease","volume":"37","author":"Takahashi","year":"2010","journal-title":"J\u00a0Dermatol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib138","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/ajd.12226","article-title":"Dabrafenib-associated necrobiotic granulomatous reaction","volume":"55","author":"Carlos","year":"2014","journal-title":"Aust J Dermatol"},{"issue":"10","key":"10.1016\/j.chest.2018.03.056_bib139","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/DAD.0000000000000281","article-title":"BRAF inhibitor-induced antitumoral granulomatous dermatitis eruption in advanced melanoma","volume":"37","author":"Garrido","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/CMR.0000000000000186","article-title":"Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib","volume":"25","author":"Jansen","year":"2015","journal-title":"Melanoma Res"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib141","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/1346-8138.13255","article-title":"Cutaneous granulomatous panniculitis and sarcoidal granulomatous papular eruption in a patient with metastatic melanoma treated with a BRAF inhibitor","volume":"43","author":"Leal","year":"2016","journal-title":"J\u00a0Dermatol"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib142","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jamadermatol.2013.7919","article-title":"Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma","volume":"150","author":"Park","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.chest.2018.03.056_bib143","first-page":"1050","article-title":"Granuloma annulare secondary to vemurafenib therapy for lung adenocarcinoma","volume":"16","author":"Jenkinson","year":"2017","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib144","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/CMR.0000000000000248","article-title":"Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation","volume":"26","author":"Henning","year":"2016","journal-title":"Melanoma Res"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib145","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/hep.28692","article-title":"Vemurafenib-induced granulomatous hepatitis","volume":"65","author":"Spengler","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib146","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MCP.0000000000000186","article-title":"How are cancer and connective tissue diseases related to sarcoidosis?","volume":"21","author":"Chopra","year":"2015","journal-title":"Curr Opin Pulm Med"},{"issue":"13-14","key":"10.1016\/j.chest.2018.03.056_bib147","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10354-014-0269-x","article-title":"Sarcoidosis vs. sarcoid-like reactions: the two sides of the same coin?","volume":"164","author":"Tchernev","year":"2014","journal-title":"Wien Med Wochenschr"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib148","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0889-857X(05)70366-5","article-title":"Methotrexate pulmonary toxicity","volume":"23","author":"Cannon","year":"1997","journal-title":"Rheum Dis Clin N Am"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib149","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib150","first-page":"243","article-title":"Drug-induced pneumonitis: the role of methotrexate","volume":"18","author":"Zisman","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib151","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000196693","article-title":"Disseminated pulmonary granulomas after intravesical bacillus Calmette-Guerin immunotherapy","volume":"64","author":"De Diego","year":"1997","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib152","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1445-2197.1998.tb04768.x","article-title":"Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment","volume":"68","author":"Paterson","year":"1998","journal-title":"Aust N Z J Surg"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib153","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.chest.2018.03.056_bib154","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory pathways in immunotherapy for cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"10.1016\/j.chest.2018.03.056_bib155","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/annonc\/mdv182","article-title":"A\u00a0systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors","volume":"26","author":"Chen","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.chest.2018.03.056_bib156","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejca.2017.05.032","article-title":"Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1\/anti-Programmed cell Death-Ligand 1 agents: a single-centre pharmacovigilance database analysis","volume":"82","author":"Le Burel","year":"2017","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib157","doi-asserted-by":"crossref","first-page":"e954506","DOI":"10.4161\/21624011.2014.954506","article-title":"Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab","volume":"3","author":"Andersen","year":"2014","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib158","doi-asserted-by":"crossref","first-page":"W992","DOI":"10.2214\/AJR.10.6198","article-title":"Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy","volume":"197","author":"Bronstein","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.chest.2018.03.056_bib159","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/2326-6066.CIR-15-0102","article-title":"Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with ipilimumab","volume":"3","author":"Tirumani","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib160","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.123.2.406","article-title":"The diagnostic pathway to sarcoidosis","volume":"123","author":"Judson","year":"2003","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib161","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.currproblcancer.2016.12.001","article-title":"Cutaneous adverse effects of the immune checkpoint inhibitors","volume":"41","author":"Collins","year":"2017","journal-title":"Curr Probl Cancer"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib162","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/MJT.0b013e3182a32ddc","article-title":"Ipilimumab granulomatous interstitial nephritis","volume":"22","author":"Thajudeen","year":"2015","journal-title":"Am J Ther"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib163","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jdcr.2016.05.002","article-title":"Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy","volume":"2","author":"Suozzi","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"14","key":"10.1016\/j.chest.2018.03.056_bib164","first-page":"1302","article-title":"CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma","volume":"24","author":"Tarhini","year":"2010","journal-title":"Oncology (Williston Park)"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib165","first-page":"601","article-title":"Releasing the brake on the immune system: ipilimumab in melanoma and other tumors","volume":"25","author":"Tarhini","year":"2010","journal-title":"Cancer Biother Radiopharm"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib166","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00262-011-1172-6","article-title":"An immune-active tumor microenvironment favors clinical response to ipilimumab","volume":"61","author":"Ji","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"10.1016\/j.chest.2018.03.056_bib167","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cncr.24951","article-title":"Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival","volume":"116","author":"Ku","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib168","first-page":"24","article-title":"Cells and cytokines involved in the pathogenesis of sarcoidosis","volume":"16","author":"Moller","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib169","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/rccm.201401-0188OC","article-title":"Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity","volume":"190","author":"Braun","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"26","key":"10.1016\/j.chest.2018.03.056_bib171","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.chest.2018.03.056_bib172","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib173","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1200\/JCO.2013.49.7735","article-title":"Antitumor granuloma formation by CD4+ T\u00a0cells in a patient with rapidly progressive melanoma experiencing spiking fevers, neuropathy, and other immune-related toxicity after treatment with ipilimumab","volume":"33","author":"Luke","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib174","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00050-2017","article-title":"Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients","volume":"50","author":"Delaunay","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2018.03.056_bib175","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/TCRM.S967","article-title":"Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis","volume":"4","author":"Callejas-Rubio","year":"2008","journal-title":"Ther Clin Risk Manage"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib176","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2125.2007.03055.x","article-title":"Clinical uses of interferons","volume":"65","author":"Friedman","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib177","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.mcp.0000134400.88832.9c","article-title":"Interferon-induced granulomatous lung disease","volume":"10","author":"Marzouk","year":"2004","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib178","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10620-009-0797-1","article-title":"Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature","volume":"55","author":"Slavenburg","year":"2010","journal-title":"Digest Dis Sci"},{"issue":"8","key":"10.1016\/j.chest.2018.03.056_bib179","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.4049\/jimmunol.165.8.4718","article-title":"Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis","volume":"165","author":"Greene","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"12","key":"10.1016\/j.chest.2018.03.056_bib180","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.4049\/jimmunol.156.12.4952","article-title":"Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis","volume":"156","author":"Moller","year":"1996","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib181","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00439-004-1099-5","article-title":"Association between IFNA genotype and the risk of sarcoidosis","volume":"114","author":"Akahoshi","year":"2004","journal-title":"Hum Genet"},{"issue":"12","key":"10.1016\/j.chest.2018.03.056_bib182","doi-asserted-by":"crossref","first-page":"e29126","DOI":"10.1371\/journal.pone.0029126","article-title":"Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestry","volume":"6","author":"Sweiss","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib183","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1148\/radiology.218.1.r01ja25242","article-title":"Newly diagnosed pulmonary sarcoidosis in HIV-infected patients","volume":"218","author":"Haramati","year":"2001","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib184","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1378\/chest.124.3.929","article-title":"Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence","volume":"124","author":"Morris","year":"2003","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib185","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.119.3.978","article-title":"Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy","volume":"119","author":"Lenner","year":"2001","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib186","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.107.3.706","article-title":"Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD","volume":"107","author":"Brice","year":"1995","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib187","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/1066896913492849","article-title":"Nitrofurantoin-induced granulomatous interstitial pneumonia","volume":"22","author":"Sakata","year":"2014","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib188","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/ckj\/sfv053","article-title":"Granulomatous interstitial nephritis","volume":"8","author":"Shah","year":"2015","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib189","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0090-4295(81)90433-7","article-title":"Nitrofurantoin-induced granulomatous hepatitis","volume":"18","author":"Sippel","year":"1981","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib190","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.1983.tb07688.x","article-title":"Multiple pyogenic granulomata occurring during etretinate therapy","volume":"109","author":"Williamson","year":"1983","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib191","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1468-3083.2008.02953.x","article-title":"Interstitial granulomatous drug reaction due to thalidomide","volume":"23","author":"Yazganoglu","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib192","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/ced.12662","article-title":"Interstitial granulomatous drug reaction induced by quetiapine","volume":"41","author":"Tan","year":"2016","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib193","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 - autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib194","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12026-017-8980-5","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants-ASIA-related to biomaterials: analysis of 45 cases and comprehensive review of the literature","volume":"66","author":"Alijotas-Reig","year":"2018","journal-title":"Immunol Res"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib195","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jbm.b.31312","article-title":"Medical-grade silicone induces release of proinflammatory cytokines in peripheral blood mononuclear cells without activating T\u00a0cells","volume":"90","author":"Miro-Mur","year":"2009","journal-title":"J\u00a0Biomed Mater Res B Appl Biomater"},{"issue":"1","key":"10.1016\/j.chest.2018.03.056_bib196","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jbm.a.32794","article-title":"Bioengineered hyaluronic acid elicited a nonantigenic T\u00a0cell activation: implications from cosmetic medicine and surgery to nanomedicine","volume":"95","author":"Alijotas-Reig","year":"2010","journal-title":"J\u00a0Biomed Mater Res A"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib197","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0961203311429317","article-title":"Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome)","volume":"21","author":"Vera-Lastra","year":"2012","journal-title":"Lupus"},{"issue":"39","key":"10.1016\/j.chest.2018.03.056_bib198","first-page":"2323","article-title":"Lofgren syndrome after silicone breast prosthesis implantation [in Hungarian]","volume":"139","author":"Barzo","year":"1998","journal-title":"Orv Hetil"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib199","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1440-1843.2003.00447.x","article-title":"Cutaneous and pulmonary sarcoidosis in a Hong Kong Chinese woman with silicone breast prostheses","volume":"8","author":"Chang","year":"2003","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/01616412.1996.11740428","article-title":"Neurosarcoidosis following augmentation mammoplasty with silicone","volume":"18","author":"Yoshida","year":"1996","journal-title":"Neurol Res"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib201","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-2133.2005.06525.x","article-title":"In situ and distant foreign body granulomas caused by silicone. Treatment with allopurinol","volume":"152","author":"Redondo","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib202","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000236791","article-title":"Remission of sarcoidosis following removal of silicone gel breast implants","volume":"105","author":"Teuber","year":"1994","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib203","first-page":"1003","article-title":"Silicone granulomatous lymphadenopathy and siliconomas of the breast","volume":"12","author":"Vaamonde","year":"1997","journal-title":"Histol Histopathol"},{"issue":"4","key":"10.1016\/j.chest.2018.03.056_bib204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5371\/hp.2016.28.4.249","article-title":"Granulomatous lung disease: a novel complication following metallosis from hip arthroplasty","volume":"28","author":"Balbouzis","year":"2016","journal-title":"Hip Pelvis"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM199607113350214","article-title":"Systemic granulomatous reaction to a foreign body after hip replacement","volume":"335","author":"Peoc'h","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib206","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2106\/00004623-199503000-00015","article-title":"Unusual foreign-body reaction to a failed total knee replacement: simulation of a sarcoma clinically and a sarcoid histologically. A case report","volume":"77","author":"Jacobs","year":"1995","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"12","key":"10.1016\/j.chest.2018.03.056_bib207","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00256-016-2492-6","article-title":"Coexisting sarcoidal granulomatous inflammation and diffuse tenosynovial giant cell tumor of the knee after a total knee replacement: a case report","volume":"45","author":"Zhang","year":"2016","journal-title":"Skelet Radiol"},{"issue":"2","key":"10.1016\/j.chest.2018.03.056_bib208","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"10.1016\/j.chest.2018.03.056_bib209","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0034-1377059","article-title":"Sarcoidosis and chronic beryllium disease: similarities and differences","volume":"35","author":"Mayer","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2018.03.056_bib210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A\u00a0concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5131","key":"10.1016\/j.chest.2018.03.056_bib211","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: a genetic marker of beryllium disease","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218306408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218306408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:58:06Z","timestamp":1762124286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369218306408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":211,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0012369218306408"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2018.03.056","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Induced Sarcoidosis-Like Reactions","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2018.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}